Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Search content at Johns Hopkins University
Home
Profiles
Research units
Research output
Engaging innate immunity in HIV-1 cure strategies
Nathan L. Board
, Milica Moskovljevic
, Fengting Wu
,
Robert F. Siliciano
,
Janet D. Siliciano
Howard Hughes Medical Institution
School of Medicine
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Engaging innate immunity in HIV-1 cure strategies'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Innate Immunity
100%
HIV Cure
100%
Human Immunodeficiency Virus Type 1 (HIV-1)
66%
Natural Killer Cells
66%
Infected Cells
66%
Latency-reversing Agents
66%
Immune Cells
33%
CD4+ T
33%
Antiretroviral Therapy
33%
Cell-based
33%
Cytolytic
33%
HIV-1 Gene
33%
Latently Infected
33%
CD8+ T Cells
33%
Dendritic Cells
33%
Progression to AIDS
33%
People Living with HIV (PLHIV)
33%
Combined Antiretroviral Therapy (cART)
33%
Multiple Stages
33%
HIV-1 Infection
33%
HIV Pathogenesis
33%
Acute Infection
33%
Strategy Use
33%
Viral Rebound
33%
Dendritic Cell Targeting
33%
Killing Activity
33%
Shock-and-kill
33%
Immunology and Microbiology
Human Immunodeficiency Virus 1
100%
Innate Immune System
100%
Dendritic Cell
42%
Natural Killer Cell
28%
Infection
28%
Acquired Immune Deficiency Syndrome
14%
Immunocompetent Cell
14%
T-Helper Cell
14%
Cytotoxic T-Cell
14%
Infectious Disease
14%
Life Cycle
14%
Rebound
14%